HBGK(SZ:300449)2023-10-27 16:00Financial Performance - The company's revenue for Q3 2023 was ¥18,684,554.01, a decrease of 50.42% compared to the same period last year[5]. - The net profit attributable to shareholders was -¥26,206,619.54, representing a 36.26% increase in losses year-over-year[5]. - The basic and diluted earnings per share were both -¥0.0879, reflecting a 36.26% increase in losses compared to the previous year[5]. - Net loss for the current period was ¥48,627,325.56, an improvement from a net loss of ¥59,713,766.86 in the previous period, representing a reduction of approximately 18.5%[20]. - Basic and diluted earnings per share were both -¥0.1630, compared to -¥0.1996 in the previous period[21]. Assets and Liabilities - Total assets at the end of the reporting period were ¥425,049,108.94, down 11.84% from the end of the previous year[5]. - The company's total liabilities were CNY 433,361,245.64, slightly down from CNY 441,800,110.17, showing a decrease of approximately 1.00%[16]. - The company's total equity remained stable at CNY 298,258,899.00, unchanged from the beginning of the year[16]. - The total equity attributable to the parent company was -¥8,278,179.57, a decrease from ¥40,340,713.11 in the previous period[20]. - The total liabilities and equity amounted to ¥425,049,108.94, down from ¥482,115,299.03 in the previous period[20]. Cash Flow - Cash flow from operating activities showed a net outflow of -¥11,272,638.30, a significant decrease of 563.45%[5]. - Cash flow from operating activities showed a net outflow of ¥11,272,638.30, a significant decline from a net inflow of ¥2,432,353.10 in the previous period[21]. - The net cash flow from investment activities was 437,838.41, with total cash outflow from investment activities amounting to 380,098.00[22]. - The net cash flow from financing activities was 10,847,320.31, while total cash outflow from financing activities reached 13,676,904.24[22]. - The cash inflow from financing activities was 24,524,224.55, with cash outflow for debt repayment at 24,240.47[22]. Expenses - Research and development expenses decreased by 52.68% to ¥5,689,808.16 compared to the same period last year[10]. - Sales expenses increased to ¥13,920,805.46, up 36.5% from ¥10,231,642.68 in the previous period[18]. - The company experienced a 96.31% increase in financial expenses, totaling ¥13,714,609.41, primarily due to reduced financing income from installment payments[10]. - Financial expenses rose to ¥13,714,609.41, compared to ¥6,986,229.42 in the previous period, indicating a significant increase[18]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 22,049, with the largest shareholder holding 5.95% of the shares[11]. - The company received government subsidies amounting to ¥430,000.00 during the reporting period, down from ¥699,800.00 in the previous period[6]. Other Information - The company has not disclosed any new product developments or market expansion strategies in the current report[14]. - The company did not undergo an audit for the third quarter report[23]. - The company has adopted new accounting standards starting in 2023, affecting the financial statements[23].